SentinelOne: Weak Fourth Quarter Further Cause For Concern
SentinelOne's share price remains under pressure due to a combination of competition concerns and mo…
seekingalpha.com
ANAB(ANAB)
ANAB
Signal
Leaning Bullish1↑1!
PRICE
Prev Close
66.76
Open
66.98
Day Range65.97 – 70.00
65.97
70.00
52W Range11.40 – 71.67
11.40
71.67
97% of range
VOLUME & SIZE
Avg Volume
858.1K
FUNDAMENTALS
P/E Ratio
-145.4x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.02
Market-like
Performance
1D
+4.52%5D
+7.09%1M
+67.70%3M
+116.37%6M
+201.30%YTD
+115.90%1Y↑
+404.92%Best: 1Y (+404.92%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +157% YoY · 99% gross marginValuation
FAIR
P/E not availableHealth
MODERATE
CR 9.1 · FCF $0.71/shBullish
Key MetricsTTM
Market Cap$3.01B
Revenue TTM$234.60M
Net Income TTM-$13.23M
Free Cash Flow$19.61M
Gross Margin99.0%
Net Margin-5.6%
Operating Margin20.4%
Return on Equity1813.8%
Return on Assets-3.6%
Debt / Equity7.81
Current Ratio9.07
EPS TTM$-0.48
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong1 watch2 concern
59/100Liquidity
9.07Strong
Leverage
7.81Concern
Coverage
0.6xConcern
ROE
1813.8%Strong
ROIC
14.6%Watch
Cash
$238MStrong
ANALYST COVERAGE21 analysts
BUY
▼ -9.7%downside to target
L $50.00
Med $63.00consensus
H $140.00Stock Health
Composite Score
4 of 5 signals bullish
9/10
Technicals
●
~RSI RangeRSI 74 — Overbought, caution
Volume
●
✓Volume FlowAccumulation — institutional buying
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 9.07 — healthy liquidity
Upcoming Events
EEarnings Report · After CloseMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 7, 2026
In 94 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ UptrendGolden Cross · 50D leads 200D by 48.2%
+26.2% vs SMA 50 · +86.9% vs SMA 200
Momentum
RSI73.9Overbought — pullback risk
MACD+1.48Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$71.67+2.7%
Current
$69.78
EMA 50
$56.27-19.4%
EMA 200
$39.39-43.5%
52W Low
$11.40-83.7%
52-Week RangeNear 52-week high
$11.4097th %ile$71.67
Squeeze SetupVolume-based
Moderate Squeeze SetupAccumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
20-Day Money Flow
Acc days:4
Dist days:0
Edge:+4 acc
Volume Context
Avg Vol (50D)907K
Recent Vol (5D)
779K-14%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 9 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $205.3M $153.5M–$234.1M | — | -$0.96 | — | ±50% | High9 |
FY2026(current) | $100.6M $89.5M–$118.7M | ▼ -51.0% | -$2.10 | — | ±50% | Moderate4 |
FY2027 | $169.8M $140.8M–$205.1M | ▲ +68.7% | -$2.34 | — | ±50% | High5 |
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 6 consecutive quarters
Earnings HistoryANAB
Last 8Q
+34.6%avg beat
Beat 6 of 8 quartersMissed 2↑ Estimates rising-6%
Q2'24
-43%
Q3'24
+34%
Q4'24
+54%
Q1'25
+2%
Q2'25
+11%
Q3'25
+149%
Q4'25
+78%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
H.C. WainwrightBuy → Neutral
Dec 11
DOWNGRADE
BTIGNeutral
Dec 2
DOWNGRADE
WedbushNeutral → Outperform
Mar 12
UPGRADE
Raymond JamesOutperform → Market Perform
Jan 6
DOWNGRADE
GuggenheimBuy
Nov 1
UPGRADE
Wells FargoUnderweight
Nov 1
DOWNGRADE
Credit SuisseNeutral
Nov 1
DOWNGRADE
Craig-HallumHold
Nov 1
DOWNGRADE
Piper SandlerNeutral
Nov 1
DOWNGRADE
Insider Activity
SEC Filings →0 Buys/6 SellsNet Selling
Schmid John P.Dir
$702K
Mar 30
SELL
Schmid John P.Dir
$427K
Mar 30
SELL
Schmid John P.Dir
$30K
Mar 30
SELL
Faga DanielDir
$29K
Mar 27
SELL
Faga DanielDir
$149K
Mar 27
SELL
Faga DanielDir
$215K
Mar 27
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
Nuveen, LLC
316K▼2
HSBC HOLDINGS PLC
126K▲3
Bleakley Financial Group, LLC
43K▼4
MOODY ALDRICH PARTNERS LLC
39K▼5
TEMA ETFS LLC
31K▲6
SG Americas Securities, LLC
25K▲7
Y-Intercept (Hong Kong) Ltd
23K▼8
Brookwood Investment Group LLC
13K▲News & Activity
ANAB News
20 articles · 4h ago
Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years
prnewswire.com
MPLX LP Reports First-Quarter 2026 Financial Results
prnewswire.com
Life Time Reports First Quarter 2026 Financial Results
prnewswire.com
TopBuild Reports First Quarter 2026 Results
globenewswire.com
Havertys Furniture Reports Operating Results for First Quarter 2026
accessnewswire.com
Target Hospitality Announces First Quarter 2026 Earnings Release and Conference Call Schedule
prnewswire.com
Marathon Petroleum Corp. Reports First-Quarter 2026 Results
prnewswire.com
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
globenewswire.com
Onity Group Announces First Quarter 2026 Results
globenewswire.com
Scorpio Tankers Inc. Announces Financial Results for the First Quarter of 2026, the Declaration of a Dividend and an Increase to its Securities Repurchase Program
globenewswire.com
SOPHiA GENETICS Reports First Quarter 2026 Results
prnewswire.com
Novo Nordisk A/S - share repurchase programme
globenewswire.com
Ares Capital: Double-Digit Yield From A Gold Standard BDC
seekingalpha.com
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
globenewswire.com
Top analyst reveals when SanDisk stock will hit $1,700
finbold.com
Grab Credits AI Investments For 23% Jump in Driver Earnings
pymnts.com
CWH Legal Alert: Camping World Hit with Securities Fraud Class Action Over Inventory Management Issues and Corresponding 24% Stock Drop
prnewswire.com
DRVN Legal Alert: Driven Brands Hit with Securities Fraud Class Action Over Financial Restatements and Corresponding 39% Stock Drop
prnewswire.com
MEDP Legal Alert: Medpace Hit with Securities Fraud Class Action Over Cancellation Rates and Corresponding 16% Stock Drop
prnewswire.com
About
founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Hamza Suria
Website
Martin DahlSenior Vice President of Research
John KwonVice President of GI Clinical Development
Daniel R. FagaPresident, Chief Executive Officer & Director
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
ANAB◀ | $69.78 | +4.52% | $3.0B | — | +15701.5% | -564.0% | 1500 |
| $68.99 | +0.00% | $13.4B | — | — | — | 1500 | |
| $91.17 | +0.00% | $12.0B | — | — | -4239.0% | 1500 | |
| $518.66 | +0.96% | $11.9B | — | — | -3008.0% | 1500 | |
| $223.70 | +8.31% | $11.4B | — | +6554.5% | -2868.8% | 1500 | |
| $76.39 | +0.00% | $10.7B | 52.9 | +2325815.3% | -19.7% | 1500 | |
| $182.03 | +0.00% | $10.6B | — | — | — | 1500 | |
| Sector avg | — | +1.97% | — | 52.9 | +782690.4% | -2139.9% | 1500 |